SILEX SYSTEMS LIMITED (SLX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SLX - SILEX SYSTEMS LIMITED

FNArena Sector : Uranium
Year End: June
GICS Industry Group : Semiconductors & Semiconductor Equipment
Debt/EBITDA: -0.14
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$5.11

01 Nov
2024

-0.140

OPEN

$5.02

-2.67%

HIGH

$5.15

246,749

LOW

$5.02

TARGET
$7.20 40.9% upside
OTHER COMPANIES IN THE SAME SECTOR
1AE . AEE . AGE . AKN . ASN . BKY . BMN . BOE . BSN . C29 . CXO . CXU . DEV . DYL . EL8 . EL8 . ERA . GLA . GTR . GUE . HAR . I88 . KOB . LAM . LOT . MEU . NXG . OAR . ORP . PDN . PEN . TOE . WCN .
FNARENA'S MARKET CONSENSUS FORECASTS
SLX: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx - 8.1 - 1.3 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-9.6
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx6.9 M
Book Value Per Share xxxxxxxxxxxxxxx55.7
Net Operating Cash Flow xxxxxxxxxxxxxxx6.1 M
Net Profit Margin xxxxxxxxxxxxxxx-330.99 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-16.20 %
Return on Invested Capital xxxxxxxxxxxxxxx-16.12 %
Return on Assets xxxxxxxxxxxxxxx-15.48 %
Return on Equity xxxxxxxxxxxxxxx-16.20 %
Return on Total Capital xxxxxxxxxxxxxxx-6.62 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx5.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx1 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx117 M
Price To Book Value xxxxxxxxxxxxxxx9.57

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx0.3 M
Capex % of Sales xxxxxxxxxxxxxxx4.16 %
Cost of Goods Sold xxxxxxxxxxxxxxx11 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx5 M
Research & Development xxxxxxxxxxxxxxx4 M
Investments - Total xxxxxxxxxxxxxxx13 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

30/08/2024

1

Buy, High Risk

$7.20

40.90%

Shaw and Partners simply notes Silex Systems has reported a FY24 net loss of -$23m.

The company is currently running uranium enrichment trials at a Test Loop pilot facility in Wilmington, North Carolina.

Success in the trials will be a potential catalyst for Cameco to exercise its option to acquire an additional 26% of the GLE joint venture, notes the broker, and should lead to US government funding.

Target $7.20. Buy, High Risk.

FORECAST
Shaw and Partners forecasts a full year FY24 dividend of 0.00 cents and EPS of minus -1.30 cents.
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -13.10 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

05/09/2024

1

Buy

$6.21

21.53%

Silex Systems' operational update highlighted depleted UF6 has been successfully loaded into the Test Loop pilot facility in Wilmington ready for laser enrichment testing.

If successful, completion will be one year earlier than originally planned and broadly in line with the accelerated schedule.

Management will participate in the bidding process after the Department of Energy in the US allocated US$2.7bn in funding to boost the "domestic nuclear fuel supply chain" and launched an LEU request for proposals.

The Speculative Buy rating and $6.21 target are maintained.

SLX STOCK CHART